Pre-metastatic niche
Pre-metastatic niche refers to the microenvironment in distant organs that is primed to support the growth of metastatic cancer cells. This concept has emerged to explain how cancer cells manage to establish metastases in specific organs and has become a significant area of research in understanding cancer progression and metastasis. The formation of a pre-metastatic niche involves changes in the target organ's local environment before the arrival of cancer cells, making it conducive for the cancer cells to engraft, survive, and proliferate.
Formation of the Pre-metastatic Niche[edit | edit source]
The formation of the pre-metastatic niche is a complex process that involves the interaction of primary tumor cells with the future metastatic site, even before the tumor cells arrive. This process is mediated by various factors secreted by the primary tumor, including growth factors, cytokines, and extracellular vesicles. These factors can alter the local microenvironment of distant organs, recruit immune cells, and induce vascular permeability, creating a favorable environment for arriving tumor cells.
Components of the Pre-metastatic Niche[edit | edit source]
Several components are crucial in the establishment of the pre-metastatic niche, including:
- Bone marrow-derived cells (BMDCs): These cells are mobilized by factors secreted by the primary tumor and home to future metastatic sites, where they can facilitate the formation of a supportive niche for metastatic cells. - Extracellular matrix (ECM) modifications: Changes in the ECM composition and structure can promote the survival and growth of metastatic cancer cells. - Vascular changes: Increased vascular permeability and angiogenesis are often observed in pre-metastatic niches, aiding in the arrival and sustenance of cancer cells. - Immune cell recruitment: The recruitment of immune cells, such as macrophages and neutrophils, can create an immunosuppressive environment that favors tumor growth.
Clinical Implications[edit | edit source]
Understanding the mechanisms underlying the formation of the pre-metastatic niche offers potential therapeutic targets to prevent or limit metastasis. Strategies to disrupt the pre-metastatic niche could include inhibiting the mobilization or function of BMDCs, preventing ECM modifications, or blocking the recruitment and immunosuppressive functions of immune cells at potential metastatic sites.
Research and Future Directions[edit | edit source]
Research in the field of pre-metastatic niches is ongoing, with studies aimed at identifying specific factors and cells involved in niche formation. The development of novel imaging techniques and animal models has facilitated the study of these processes in vivo. Future research directions include the identification of biomarkers for early detection of pre-metastatic niches and the development of therapies targeting these niches to prevent metastasis.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD